Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_assertion type Assertion NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_head.
- NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_assertion description "[Here, we show that in clinical samples bladder tumors with intense expression of stem cell marker Oct-3/4 (also known as POU5F1) are associated with further disease progression, greater metastasis, and shorter cancer-related survival compared with those with moderate and low expressions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_provenance.
- NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_assertion evidence source_evidence_literature NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_provenance.
- NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_assertion SIO_000772 18676852 NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_provenance.
- NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_assertion wasDerivedFrom befree-2016 NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_provenance.
- NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_assertion wasGeneratedBy ECO_0000203 NP685817.RAWbc1s7hMy4DjDFizcH9odUx9OKD-z54vbha9xr5J3OE130_provenance.